Pieris Pharmaceuticals
(NASDAQ:PIRS)
$0.18
-0.0137[-7.07%]
At close: Mar 28
$0.18
0[0.00%]
After Hours: 7:46PM EDT
37.5%
Overview Rating
Speculative
Technicals Analysis
33
0100
Financials Analysis
40
0100
40%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
0
0
0
0
Feb
0
0
0
0
Jan
0
0
0
0
Dec 23
0
0
0
0
Nov 23
0
0
0
0
Oct 23
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
-
No Rating
Strong Buy
Buy
Hold
Sell
Strong Sell
About Pieris Pharmaceuticals Inc
Sector
Health Care
Industry
Biotechnology
Pieris Pharmaceuticals Inc is a clinical-stage biopharmaceutical company, which engages in the disco...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
PIRS
GLTO

FAQ

Q

How do I buy Pieris Pharmaceuticals (PIRS) stock?

A

You can purchase shares of Pieris Pharmaceuticals (NASDAQ: PIRS) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Pieris Pharmaceuticals's (PIRS) competitors?

Q

What is the target price for Pieris Pharmaceuticals (PIRS) stock?

A

The latest price target for Pieris Pharmaceuticals (NASDAQ: PIRS) was reported by Baird on Friday, March 13, 2020. The analyst firm set a price target for 5.00 expecting PIRS to rise to within 12 months (a possible 2677.78% upside). 0 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Pieris Pharmaceuticals (PIRS)?

A

The stock price for Pieris Pharmaceuticals (NASDAQ: PIRS) is $0.18 last updated March 28, 2024 at 7:46 PM EDT.

Q

Does Pieris Pharmaceuticals (PIRS) pay a dividend?

A

There are no upcoming dividends for Pieris Pharmaceuticals.

Q

When is Pieris Pharmaceuticals (NASDAQ:PIRS) reporting earnings?

A

Pieris Pharmaceuticals’s Q4 earnings are confirmed for Tuesday, February 28, 2023.

Q

Is Pieris Pharmaceuticals (PIRS) going to split?

A

There is no upcoming split for Pieris Pharmaceuticals.

Q

What sector and industry does Pieris Pharmaceuticals (PIRS) operate in?

A

Pieris Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch